Back to Search Start Over

Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity.

Authors :
Reynolds RM
Pesonen AK
O'Reilly JR
Tuovinen S
Lahti M
Kajantie E
Villa PM
Laivuori H
Hämäläinen E
Seckl JR
Räikkönen K
Source :
Psychological medicine [Psychol Med] 2015 Jul; Vol. 45 (10), pp. 2023-30. Date of Electronic Publication: 2015 Jan 28.
Publication Year :
2015

Abstract

Background: Maternal prenatal depression predicts post-partum depression and increases risk of prematurity and low birth weight. These effects may be mediated by altered placental function. We hypothesized that placental function would be influenced by the gestational week of experiencing depressive symptoms and aimed to examine associations between maternal depressive symptoms during pregnancy and placental expression of genes involved in glucocorticoid and serotonin transfer between mother and fetus.<br />Method: We studied women participating in a prospective pregnancy cohort: the Prediction and Prevention of Preeclampsia (PREDO) Study, Helsinki, Finland. Maternal depressive symptoms were assessed at 2-week intervals throughout pregnancy in 56 healthy women with singleton, term pregnancies. Messenger ribonucleic acid (mRNA) levels of glucocorticoid (GR) and mineralocorticoid (MR) receptors and serotonin transporter (SLC6A4), 11β-hydroxysteroid dehydrogenase type 1 (HSD1) and 2 (HSD2) were quantified in placental biopsies.<br />Results: In adjusted analyses women who reported higher depressive symptoms across the whole pregnancy had higher mRNA levels of GR [effect size 0.31 s.d. units, 95% confidence interval (CI) 0.01-0.60, p = 0.042] and MR (effect size 0.34 s.d. units, 95% CI 0.01-0.68, p = 0.047). These effects were significant for symptoms experienced in the third trimester of pregnancy for GR; findings for MR were also significant for symptoms experienced in the second trimester. GR and MR mRNA levels increased linearly by having the trimester-specific depressive symptoms scores 0, 1 or 2-3 times above the clinical cut-off for depression (p = 0.003, p = 0.049, respectively, and p = 0.004, p = 0.15 in adjusted analyses).<br />Conclusions: Our findings offer potential gestational-age-specific mechanisms linking maternal depressive symptoms during pregnancy via placental biology. Future studies will test whether these also link with adverse offspring outcomes.

Details

Language :
English
ISSN :
1469-8978
Volume :
45
Issue :
10
Database :
MEDLINE
Journal :
Psychological medicine
Publication Type :
Academic Journal
Accession number :
25628053
Full Text :
https://doi.org/10.1017/S003329171400316X